Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Sovanlal Mukherjee, Ph.D., studies artificial intelligence (AI) applications in medical imaging and radiology. With a background in electrical engineering and medical image processing, Dr. Mukherjee conducts research in radiomics-based machine learning (ML), deep learning-based segmentation and predictive modeling. He develops AI algorithms for early detection of pancreatic ductal adenocarcinoma and for volumetric pancreas and pancreatic tumor segmentation. He also uses multimodal imaging data for survival prediction. His prior research includes innovations in radiation therapy planning and image denoising for low-dose computerized tomography (CT) scans.
Early pancreatic cancer detection. Dr. Mukherjee developed a radiomics-based ML model that detects early pancreatic ductal adenocarcinoma, a common form of pancreatic cancer, using prediagnostic CT scans. The model achieved 92.2% accuracy, significantly outperforming human radiologists. Tested on a large dataset, the model also demonstrated robustness against image perturbations, making it a promising tool for early diagnosis of pancreatic ductal adenocarcinoma.
Building on this success, Dr. Mukherjee developed another radiomics-based ML model for the early detection of pancreatic ductal adenocarcinoma. This model, called REDMOD, was particularly trained on a high control-to-case ratio to reflect low-prevalence screening of pancreatic ductal adenocarcinoma. The model's performance has also significantly surpassed that of human radiologists.
Volumetric pancreatic ductal adenocarcinoma segmentation using AI. To address challenges in pancreatic ductal adenocarcinoma and pancreatic tumor segmentation, Dr. Mukherjee created a bounding box-based convolutional neural network model that focuses on peritumoral anatomy for pancreatic ductal adenocarcinoma segmentation. This semiautomated approach achieved extremely high segmentation accuracy and generalized well across multi-institutional datasets, improving the reliability of imaging biomarkers for the disease.
Based on the success of the semiautomated approach, Dr. Mukherjee developed another convolutional neural network model for fully automated pancreatic ductal adenocarcinoma segmentation. This automated version paves the way for various biomarker extraction from the pancreatic ductal adenocarcinoma region for potential applications, including survival analyses and prediction of treatment response and risk.
Dr. Mukherjee primarily develops AI tools that help medical teams find pancreatic cancer sooner when it is most treatable. These tools can spot signs of cancer in scans months before symptoms appear, giving patients a better chance at treatment. His research also creates faster and more accurate ways to plan radiation therapy and improve image quality in low-dose scans, making care safer and more effective.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.